ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19,887,002 | +145.2% | 830,355 | +92.7% | 0.24% | +114.5% |
| Q1 2023 | $8,109,632 | +25.3% | 430,905 | +8.9% | 0.11% | +22.2% |
| Q3 2022 | $6,471,000 | +76.7% | 395,549 | +52.2% | 0.09% | +60.7% |
| Q2 2022 | $3,663,000 | -62.3% | 259,967 | -37.5% | 0.06% | -59.7% |
| Q4 2021 | $9,714,000 | -0.7% | 416,200 | -29.3% | 0.14% | -13.1% |
| Q3 2021 | $9,781,000 | -39.5% | 588,859 | -11.2% | 0.16% | -47.0% |
| Q2 2021 | $16,172,000 | +60.5% | 663,054 | +69.8% | 0.30% | +34.8% |
| Q1 2021 | $10,077,000 | +270.2% | 390,591 | +667.2% | 0.22% | +211.1% |
| Q4 2020 | $2,722,000 | -79.8% | 50,913 | -84.5% | 0.07% | -83.7% |
| Q3 2020 | $13,506,000 | +352.5% | 327,415 | +431.7% | 0.44% | +275.4% |
| Q2 2020 | $2,985,000 | – | 61,575 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |